bluuebunny/crossref_metadata_2025_split huggingface dataset:
Selected ‘Starter Kit’ energy system modelling data for Central African Republic (#CCG)
Authors: Allington Lucy , Cannone Carla , Pappis Ioannis , Barron Karla Cervantes , Usher Will , Pye Steve , Brown Edward , Howells Mark , Taliotis Constantinos , Sundin Caroline , Sridha Vignesh , Ramos Eunice , Brinkerink Maarten , Deane Paul , Gritsevskyi Andrii , Moura Gustavo , Rouget Arnaud , Wogan David , Barcelona Edito , Rogner Holger , Cronin Jen , Hirmer Stephanie 
Published: April 2021

Abstract
Energy system modelling can be used to assess the implications of different scenarios and support improved policymaking. However, access to data is often a barrier to starting energy system modelling in developing countries, thereby causing delays. Therefore, this article provides data that can be used to create a simple zero order energy system model for Central African Republic, which can act as a starting point for further model development and scenario analysis. The data are collected entirely from publicly available and accessible sources, including the websites and databases of international organizations, journal articles, and existing modelling studies. This means that the dataset can be easily updated based on the latest available information or more detailed and accurate local data. These data were also used to calibrate a simple energy system model using the Open Source Energy Modelling System (OSeMOSYS) and three stylized scenarios (Fossil Future, Least Cost and Net Zero by 2050) for 2020–2050. The assumptions used and results of these scenarios are presented in the appendix as an illustrative example of what can be done with these data. This simple model can be adapted and further developed by in-country analysts and academics, providing a platform for future work.
Selected ‘Starter Kit’ energy system modelling data for Equatorial Guinea (#CCG)
Authors: Allington Lucy , Cannone Carla , Pappis Ioannis , Barron Karla Cervantes , Usher Will , Pye Steve , Brown Edward , Howells Mark , Taliotis Constantinos , Sundin Caroline , Sridha Vignesh , Ramos Eunice , Brinkerink Maarten , Deane Paul , Gritsevskyi Andrii , Moura Gustavo , Rouget Arnaud , Wogan David , Barcelona Edito , Rogner Holger , Hirmer Stephanie 
Published: April 2021

Abstract
Energy system modelling can be used to assess the implications of different scenarios and support improved policymaking. However, access to data is often a barrier to starting energy system modelling in developing countries, thereby causing delays. Therefore, this article provides data that can be used to create a simple zero order energy system model for Equatorial Guinea, which can act as a starting point for further model development and scenario analysis. The data are collected entirely from publicly available and accessible sources, including the websites and databases of international organizations, journal articles, and existing modelling studies. This means that the dataset can be easily updated based on the latest available information or more detailed and accurate local data. These data were also used to calibrate a simple energy system model using the Open Source Energy Modelling System (OSeMOSYS) and two stylized scenarios (Fossil Future and Least Cost) for 2020–2050. The assumptions used and results of these scenarios are presented in the appendix as an illustrative example of what can be done with these data. This simple model can be adapted and further developed by in-country analysts and academics, providing a platform for future work.
Selected ‘Starter Kit’ energy system modelling data for Eritrea (#CCG)
Authors: Cannone Carla , Allington Lucy , Pappis Ioannis , Barron Karla Cervantes , Usher Will , Pye Steve , Brown Edward , Howells Mark , Walker Miriam Zachau , Ahsan Aniq , Charbonnier Flora , Halloran Claire , Hirmer Stephanie , Taliotis Constantinos , Sundin Caroline , Sridha Vignesh , Ramos Eunice , Brinkerink Maarten , Deane Paul , Gritsevskyi Andrii , Moura Gustavo , Rouget Arnaud , Wogan David , Barcelona Edito , Rogner Holger , Cronin Jen 
Published: April 2021

Abstract
Energy system modelling can be used to assess the implications of different scenarios and support improved policymaking. However, access to data is often a barrier to starting energy system modelling in developing countries, thereby causing delays. Therefore, this article provides data that can be used to create a simple zero order energy system model for Eritrea, which can act as a starting point for further model development and scenario analysis. The data are collected entirely from publicly available and accessible sources, including the websites and databases of international organizations, journal articles, and existing modelling studies. This means that the dataset can be easily updated based on the latest available information or more detailed and accurate local data. These data were also used to calibrate a simple energy system model using the Open Source Energy Modelling System (OSeMOSYS) and three stylized scenarios (Fossil Future, Least Cost and Net Zero by 2050) for 2020–2050. The assumptions used and results of these scenarios are presented in the appendix as an illustrative example of what can be done with these data. This simple model can be adapted and further developed by in-country analysts and academics, providing a platform for future work.
A field analysis trial comparing the turnaround times of routine and STAT red blood cell immunohematology testing
Authors: Sackett K. , Kjell A. , Schneider A.M. , Cohn C.S. 
Published: April 2021

Abstract
The turnaround time (TAT) for pre-transfusion testing is important for prompt clinical decision-making. TAT includes the time between the arrival of the sample and the initiation of testing, plus the processing time (PT) required to generate and report a result. The TAT in larger blood banks is mostly dependent upon the capability of the analyzer used. In smaller blood banks, where manual work is often performed, the TAT is dependent on availability and experience of staff, testing resources, and workload. Our site performed a comparative analysis of the ORTHO VISION® (Ortho Clinical Diagnostics, Raritan, NJ) and the Echo® (Immucor, Norcross, GA) blood bank analyzers, using the TAT and PT of standard blood bank tests as the outcome metrics. Tests were run in various combinations to reflect the standard workflow of a busy hospital transfusion service and under routine and immediate or STAT conditions. We also compared manual versus automated processing TATs for a variety of pre-transfusion tests and antibody titers. We found that the capacity of the VISION to load and run new samples, even while several other tests were ongoing, allowed for faster overall TAT when compared with samples run on the Echo. The PTs of the two analyzers (from load to result) were also compared, and we found them to be equivalent. These findings highlight the inherent flaw in considering only PT when assessing a laboratory’s ability to efficiently and consistently make results available to best meet customer and patient needs. In addition, we observed a tighter distribution of TATs and PTs when the VISION was compared with the Echo analyzer, providing a higher level of predictability for availability of results. Finally, when compared with manual antibody titer testing, the VISION analyzer showed a faster PT.
Immunohematology

2017;33:1–5.
Use of standard laboratory methods to obviate routine dithiothreitol treatment of blood samples with daratumumab interference
Authors: Lintel N.J. , Brown D.K. , Schafer D.T. , Tsimba-Chitsva F.M. , Koepsell S.A. , Shunkwiler S.M. 
Published: April 2021

Abstract
Daratumumab is an antibody currently used in the treatment of patients with refractory multiple myeloma. Blood samples from patients being treated with daratumumab may show panreactivity during pre-transfusion testing. To facilitate the provision of blood components for such patients, it is recommended that a baseline phenotype or genotype be established prior to starting treatment with daratumumab. If patient red blood cells (RBCs) require phenotyping after the start of daratumumab treatment, dithiothreitol (DTT) treatment of the patient’s RBCs should be performed. The medical charts of four patients treated with daratumumab were reviewed. The individual number of doses ranged from 1 to 14; patient age ranged from 55 to 78 years; two men and two women were included in the review. Type and screen data were obtained from samples collected over 33 encounters with a range of 1 to 13 encounters per patient. All samples were tested initially by automated solid-phase testing. Any reactivity with solid phase led to tube testing with either low-ionic-strength saline, polyethylene glycol, or both. If incubation failed to eliminate the reactivity, the sample was sent to a reference laboratory for DTT treatment and phenotyping. Of the 33 samples tested, 23 (69.7%) samples had reactivity in solid-phase testing. In 8 of the 10 samples that did not react in solid-phase, testing was conducted more than four half-lives after the last dose of daratumumab. Of the 23 that had reactivity in solid-phase, 16 (69.6%) samples demonstrated loss of reactivity using common laboratory methods. For the seven patients whose sample reactivity was not initially eliminated, six were provided with phenotypically matched blood based on prior molecular testing. Only one sample was sent out for DTT treatment. These results suggest that daratumumab interference with pre-transfusion testing can be addressed using common laboratory methods. This finding could save time and money for laboratories that do not have DTT available.
Immunohematology

2017;33:22–26.
Recognizing and resolving ABO discrepancies
Authors: Meny G.M. 
Published: April 2021

Abstract
Patient samples are routinely typed for ABO prior to transfusion. Determining the ABO group requires both red blood cell (RBC) antigen typing for A and B (forward type) and testing for anti-A and anti-B in the plasma (reverse type). An ABO discrepancy exists when the result of an ABO RBC typing, or forward type, does not agree with the result of the plasma typing, or reverse type. This brief review examines several causes of ABO discrepancies encountered in the clinical transfusion service. Options for resolving these discrepancies are presented, including a discussion of which discrepancies should be resolved using molecular testing. Finally, case studies illustrate transfusion options in patients with ABO discrepancies. Discrepancies can also be encountered when ABO typing is performed on samples from blood or tissue donors, although those discrepancies will not be discussed in this review.
Immunohematology

2017;33:76–81.
Stability guidelines for dithiothreitol-treated red blood cell reagents used for antibody detection methods in patients treated with daratumumab
Authors: Disbro W.L. 
Published: April 2021

Abstract
Daratumumab (DARA), a drug used to treat patients with multiple myeloma, causes interference in pre-transfusion testing. Samples from patients receiving DARA exhibit panreactivity in antibody detection and identification tests with red blood cells (RBCs). Many hospitals are sending these samples to reference laboratories. Dithiothreitol (DTT), a sulfhydryl chemical treatment of RBCs, negates this reactivity. This study investigated the stability of the antigens on DTT-treated RBCs to determine if large quantities of RBCs could be treated at one time, stored, and used for testing at a later time. Panel cells were treated with DTT and then stored as three sets. Set 1 DTT-treated RBCs were stored in Alsever’s solution at 2°C to 8°C, washed daily, and suspended in pH 7.3 phosphate-buffered saline (PBS) prior to antigen typing. Set 2 DTT-treated RBCs were stored in pH 7.3 PBS. Set 3 DTT-treated RBCs were stored in Alsever’s solution. Sets 2 and 3 were inspected daily for 14 days for observation of hemolysis. In Set 1, all antigen reactivity remained at ≥2+ with both single- and double-dose cells for 14 days. The Rh antigens gave stronger reactions longer, compared with those tested in the Duffy, Kidd, and MNS blood group systems. Sets 2 and 3 were monitored for hemolysis. On day 3, Set 2 began displaying hemolysis, with complete hemolysis by day 8. Set 3 did not display hemolysis in 14 days. In conclusion, a large volume of RBCs can be treated with DTT and stored in Alsever’s solution for use without deterioration of the RBC antigens, saving institutions tech time, resources, and money.
Immunohematology

2017;33: 105–109.
Clinical and laboratory profile of anti-M
Authors: Basu D. , Basu S. , Reddy M. , Gupta K. , Chandy M. 
Published: April 2021

Abstract
Anti-M is a frequently detected naturally occurring antibody that has been reported in various clinical settings and also in voluntary donors. We describe here the clinical and laboratory findings of 11 cases with anti-M detected at our center. This report is a retrospective study in which we reviewed our immunohematology laboratory records for cases involving anti-M. Both donor and patient data from a 28-month period (September 2014 to December 2016) were reviewed. During this period, 11 examples of anti-M were detected (8 patients, 1 voluntary whole blood donor, and 1 hematopoietic stem cell donor. Anti-M was also detected in one external quality assessment scheme sample received during this period. In conclusion, anti-M can be detected in various clinical settings. This antibody can be clinically significant; in the laboratory, it can present as a serologic problem such as an ABO group discrepancy or an incompatible crossmatch. After detection, management and course of action is determined by both the antibody characteristics and the clinical setting.
Immunohematology

2017;33:165–169.
Dithiothreitol treatment of red blood cells
Authors: Bub C.B. 
Published: April 2021

Abstract
Dithiothreitol (DTT), a reducing reagent, has multiple applications in blood bank testing. DTT disrupts the bridging of the disulfide bonds between amino acid residues necessary for structural conformation of some proteins and the bonds holding an IgM molecule in the pentameric formation. DTT treatment of red blood cells (RBCs) can denature or modify certain blood group antigens—in particular, those in the Kell, Lutheran, YT, JMH, LW, Cromer, Indian, Dombrock, and Knops systems—and prevent recognition by the corresponding antibodies. It also destroys RBC CD38, allowing DTT-treated RBCs to be used to avoid testing interference by therapeutic anti-CD38 preparations. DTT treatment can be used to disperse spontaneous agglutination of RBCs caused by heavy IgM autoantibody coating that invalidates ABO/Rh cell grouping and direct antiglobulin tests.
Immunohematology

2017;33:170–172.
The H blood group system
Authors: Scharberg E.A. , Olsen C. , Bugert P. 
Published: April 2021

Abstract
The H blood group system, ISBT symbol H (018), consists of a single antigen (H) defined by a terminal fucose residue found on red blood cells and in secretions formed by the action of α-1,2-fucosyltransferases 1 (α2FucT1) and 2 (α2FucT2), respectively. Mutant alleles of the corresponding FUT1 and FUT2 genes result in either a H– phenotype (Bombay phenotype, Oh) or a weak H phenotype (para-Bombay, H+w). In addition, the FUT2 gene is the molecular basis of the secretor (Se) status, and homozygosity or compound heterozygosity for null alleles is associated with the nonsecretor (se) status. H– individuals have natural anti-H (mostly IgM), which can cause severe hemolytic transfusion reactions with intravascular hemolysis.
Immunohematology

2016;32:112–118.
US Privacy Laws Go Against Public Preferences and Impede Public Health and Research: Survey Study
Authors: Schmit Cason , Giannouchos Theodoros , Ramezani Mahin , Zheng Qi , Morrisey Michael A , Kum Hye-Chung 
Published: April 2021

Background
Reaping the benefits from massive volumes of data collected in all sectors to improve population health, inform personalized medicine, and transform biomedical research requires the delicate balance between the benefits and risks of using individual-level data. There is a patchwork of US data protection laws that vary depending on the type of data, who is using it, and their intended purpose. Differences in these laws challenge big data projects using data from different sources. The decisions to permit or restrict data uses are determined by elected officials; therefore, constituent input is critical to finding the right balance between individual privacy and public benefits.

Objective
This study explores the US public’s preferences for using identifiable data for different purposes without their consent.

Methods
We measured data use preferences of a nationally representative sample of 504 US adults by conducting a web-based survey in February 2020. The survey used a choice-based conjoint analysis. We selected choice-based conjoint attributes and levels based on 5 US data protection laws (Health Insurance Portability and Accountability Act, Family Educational Rights and Privacy Act, Privacy Act of 1974, Federal Trade Commission Act, and the Common Rule). There were 72 different combinations of attribute levels, representing different data use scenarios. Participants were given 12 pairs of data use scenarios and were asked to choose the scenario they were the most comfortable with. We then simulated the population preferences by using the hierarchical Bayes regression model using the ChoiceModelR package in R.

Results
Participants strongly preferred data reuse for public health and research than for profit-driven, marketing, or crime-detection activities. Participants also strongly preferred data use by universities or nonprofit organizations over data use by businesses and governments. Participants were fairly indifferent about the different types of data used (health, education, government, or economic data).

Conclusions
Our results show a notable incongruence between public preferences and current US data protection laws. Our findings appear to show that the US public favors data uses promoting social benefits over those promoting individual or organizational interests. This study provides strong support for continued efforts to provide safe access to useful data sets for research and public health. Policy makers should consider more robust public health and research data use exceptions to align laws with public preferences. In addition, policy makers who revise laws to enable data use for research and public health should consider more comprehensive protection mechanisms, including transparent use of data and accountability.
Benefits of Digital Health Resources for Substance Use Concerns in Women: Scoping Review
Authors: Quilty Lena , Agic Branka , Coombs Michelle , Kristy Betty-Lou , Shakespeare Jill , Spafford Adrienne , Besa Reena , Dematagoda Shadini , Patel Alina , Persaud Rebecca , Buckley Leslie 
Published: April 2021

Background
Digital health resources are being increasingly used to support women with substance use concerns. Although empirical research has demonstrated that these resources have promise, the available evidence for their benefit in women requires further investigation. Evidence supports the capacity of interventions that are sex-, gender-, and trauma-informed to improve treatment access and outcomes and to reduce health system challenges and disparities. Indeed, both sex- and gender-specific approaches are critical to improve health and gender equity. Violence and trauma are frequent among those with substance use concerns, but they disproportionately affect those who identify as female or women, further underscoring the need for trauma-informed care as well.

Objective
The objective of this investigation was to evaluate the evidence supporting the efficacy or effectiveness of online or mobile interventions for risky or harmful substance use in adults who identify as female or women, or who report a history of trauma.

Methods
This scoping review is based on an academic search in MEDLINE, APA PsycINFO, Embase, Cochrane Central, and CINAHL, as well as a grey literature search in US and Canadian government and funding agency websites. Of the 7807 records identified, 465 remained following title and abstract screening. Of these, 159 met all eligibility criteria and were reviewed and synthesized.

Results
The 159 records reflected 141 distinct studies and 125 distinct interventions. Investigations and the interventions evaluated predominantly focused on alcohol use or general substance use. Evaluated digital health resources included multisession and brief-session interventions, with a wide range of therapeutic elements. Multisession online and mobile interventions exhibited beneficial effects in 86.1% (105/122) of studies. Single-session interventions similarly demonstrated beneficial effects in 64.2% (43/67) of study conditions. Most investigations did not assess gender identity or conduct sex- or gender-based analyses. Only 13 investigations that included trauma were identified.

Conclusions
Despite the overall promise of digital health interventions for substance use concerns, direct or quantitative evidence on the efficacy or effectiveness of interventions in females or women specifically is weak.
Pelatihan Pemahaman Multikulturalisme pada Komunitas Nahdlatul Ulama di Desa Tamantirta, Kasihan, Bantul
Authors: Akhyat Arif 
Published: April 2021

Multiculturalism is a new concept in social science that is used to be the main discussion in community service activities at Jam'iyyah and Jama'ah Nahdlatul Ulama (NU) in Tamantirto Village, Kasihan, Bantul, Yogyakarta. Through the concept of multiculturalism, Jama'ah and Jam'iyyah NU began to try to understand the teachings of NU which have the same principles as Tasawasuth, Tasamuh, Tawazun and I'tidal. With a mixture of online (Whatapps Group and WA Japri) and offline (direct FGD) methods, this service has provided the concept of multiculturalism as a training subject to Jama'ah and Jam'iyyah of NU. The results achieved in this service, opened an understanding of tolerance, the concept of Islamic brotherhood (Ukhuuwah Islamiyah) and a pluralistic social awareness. The emergence of this awareness of multiculturalism, although among NU circles, often referred to the concepts of Tawasuth, Tasamuh, Tawazun and I'tidal, Jama'ah began to expand the way of life in society amidst differences and complex social networks.
=====
Multikulturalisme sebagai konsep baru dalam ilmu sosial menjadi pembahasan pokok dalam kegiatan pengabdian pada Jam’iyyah maupun Jama’ah Nahdlatul Ulama (NU) di Desa Tamantirto, Kasihan, Bantul, Yogyakarta. Melalui konsep multikulturalisme, Jama’ah maupun Jam’iyyah NU mulai mencoba memahami dan mengaitkan dengan ajaran NU yang memiliki kesamaan prinsip dengan Tasawasuth, Tasamuh, Tawazun dan I’tidal. Dengan metode campuran daring (Whatapps Group dan WA Japri) dan luring (FGD langsung), pengabdian ini telah memberikan pengenalan konsep multikulturalisme kepada Jama’ah dan Jam’iyyah NU sebagai praktik sosial-keagamaan. Hasil yang dicapai pada pengabdian ini, terbukanya pemahaman tentang toleransi, konsep persaudaraan Islamiyah (Ukhuuwah Islamiyah) dan kesadaran bermasyarakat yang majemuk. Munculnya kesadaran multikulturalisme ini, walaupun di kalangan NU, sering merujuk pada konsep Tawasuth, Tasamuh, Tawazun dan I’tidal, namun Jama’ah mulai semakin luas cara hidup bermasyarakat di tengah-tengah perbedaan dan jaringan sosial yang rumit.